Loading provider…
Loading provider…
Hematology & Oncology Physician in Charlottesville, VA
NPI: 1093884611Primary Practice Location
UNIVERSITY OF VIRGINIA MEDICAL CENTER
1215 Lee St, Charlottesville, VA
Primary Employer
UVA Physicians Group
virginia.edu
HQ Phone
Get Michael's Phone Numberphone_androidMobile
Get Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardVA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 50 | 212 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 48 | 115 |
| 3 | 99238Hospital discharge day management, 30 minutes or less | 17 | 18 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 17 | 17 |
Treatment of Refractory ALK Rearranged Anaplastic Large Cell Lymphoma With Alectinib.
Authors: Craig Portell, Richard Hall, Ryan Gentzler, Daniel Reed, Leonid Volodin
Journal: Clin Lymphoma Myeloma Leuk
Publication Date: 2019-03-11
Lead Sponsor: University of Virginia
Collaborators: Pfizer, Vanderbilt University, Virginia Commonwealth University, University of Wisconsin, Madison
Intervention / Treatment: DRUG: Cytarabine, DRUG: Methotrexate, DRUG: Vincristine, DRUG: Daunorubicin, DRUG: Pegaspargase, DRUG: Inotuzumab ozogamicin, DRUG: Prednisone Pill
Lead Sponsor: Seagen Inc.
Intervention / Treatment: DRUG: carboplatin, DRUG: ifosfamide, DRUG: rituximab, DRUG: etoposide, DRUG: denintuzumab mafodotin